Anthony Vecchione
The company will use the funds to move into the female health space and increase screening and preventive care.
The funds will be used to increase the development of GAIA-based Alzheimer's disease drugs and widen the pipeline of blockbuster drug candidates.
AI and synthetic-driven research can help clinicians gain a patient's trust, according to Adrienne Boissy, Qualtrics CMO.
The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.
Developing an AI platform internally can be more cost-effective and manageable, said Ryan Sadeghian, chief medical information officer at the University of Toledo, at HIMSS AI Forum.
In a panel discussion, IT professionals and health system executives discussed the challenges of implementing AI across diverse healthcare settings.
ArteraAI Prostate analyzes digital pathology images of a prostate cancer biopsy slide to help clinicians predict long-term outcomes.
The organizations will co-develop AI playbooks, tools, a new certification program and best practices for health AI.
The Focalist system aims to combine handheld robotics with real-time imaging to enable clinicians to place needles more precisely.
The company will use the funds for a European feasibility study for its transcatheter device and for the launch of a U.S.-based clinical study.